The trial follows earlier signs that GLP-1s can reduce symptoms of alcohol and drug addiction similarly to how they reduce ...

The U.S. Department of Veterans Affairs has launched a new clinical trial to determine whether GLP-1 medications, the ...

The new Cessation or Reduction of Alcohol Consumption in Veterans trial, or “CRAVE trial,” will see if the popular weight loss drug can curb alcohol use.

The Michael E. DeBakey VA Medical Center is one of 18 VA sites participating in a national clinical trial involving ...

A clinical trial from the University of Colorado Anschutz found oral semaglutide, the medication behind Ozempic and Wegovy ...

A clinical trial led by researchers at CU Anschutz has found that oral semaglutide, a medication widely used for diabetes and ...

The VA has launched a trial to test Ozempic and Wegovy for alcohol use disorder in veterans.

Glucagon-like peptide-1 (GLP-1) receptor agonist use is booming in the U.S., and it’s ushering in waves of reports of people ...

Alcohol withdrawal seizures can strike 24 to 48 hours after the last drink, turning wilderness settings into life-threatening ...

Altimmune’s Phase 2 trial showed Pemvidutide reduced heavy drinking by 4.20 days per week compared with the placebo’s 2.75 ...

More than 29.5 million Americans ages 12 and up had alcohol use disorder—the medical term for the disease commonly known as alcoholism—in 2022, when the most recent national data was published. The ...